Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Human leukocyte antigens (HLA) are a group of genes within the major histocompatibility complex (MHC) located on chromosome 6 in humans. These genes encode cell-surface proteins that play a central role in regulating the immune system by distinguishing between self and non-self molecules. HLA molecules are essential for presenting antigenic peptides to T-cell receptors, thereby initiating immune responses against pathogens or abnormal cells. They are critical for immune surveillance, transplantation compatibility, and are associated with various autoimmune diseases.
Binding and presentation of antigenic peptides to T-cell receptors, triggering immune responses. Drugs can modulate HLA expression or block HLA-TCR interaction.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Human Leukocyte Antigen (HLA).